Literature DB >> 18343546

Giant neglected ameloblastoma: single stage treatment and clinicopathological review.

Nicholas Kalavrezos1, David James Baldwin, D Murray Walker.   

Abstract

Giant ameloblastomas may present with massive swelling of the jaws. We report a giant ameloblastoma of the mandible in a Nigerian patient that measured 15.1x12.2x13.6cm and was managed with a single procedure. The tumour was removed by segmental mandibulectomy and reconstructed with a fibular free flap. The excess soft tissue was treated with a bilateral commissuroplasty. Single stage treatment that establishes early functional and aesthetic recovery offers advantages over multi staged procedures, and is therefore the treatment of choice for giant ameloblastomas.

Entities:  

Mesh:

Year:  2008        PMID: 18343546     DOI: 10.1016/j.bjoms.2008.02.001

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  4 in total

1.  Retrospective Review of the Anaesthetic Management of Maxillectomies and Mandibulectomies for Benign Tumours in Sub-Saharan Africa.

Authors:  Michelle C White; Katherine C Horner; Peggy S Lai
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

2.  Rare giant granular cell ameloblastoma: a case report and an immunohistochemical study.

Authors:  Santosh Hunasgi; Anila Koneru; Dinesh Singh Chauhan; Yadavalli Guruprasad
Journal:  Case Rep Dent       Date:  2013-03-07

3.  Defining giant mandibular ameloblastomas - Is a separate clinical sub-entity warranted?

Authors:  Aditya V Kanoi; Tibar Banerjee; Narayanamurthy Sundaramurthy; Arindam Sarkar; Pooja Kanoi; Sushovan Saha
Journal:  Indian J Plast Surg       Date:  2018 May-Aug

4.  Solid ameloblastomas - Retrospective clinical and histopathologic study of 54 cases.

Authors:  Giovana Medeiros Fulco; Cassiano Francisco Weege Nonaka; Lélia Batista de Souza; Márcia Cristina da Costa Miguel; Leão Pereira Pinto
Journal:  Braz J Otorhinolaryngol       Date:  2010 Mar-Apr
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.